These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Agents against cytokine synthesis or receptors. Yamagata T; Ichinose M Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805 [TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here? Giembycz MA Drugs; 2000 Feb; 59(2):193-212. PubMed ID: 10730545 [TBL] [Abstract][Full Text] [Related]
5. Targeting Th2 cells in asthmatic airways. Caramori G; Ito K; Adcock IM Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):243-55. PubMed ID: 15379592 [TBL] [Abstract][Full Text] [Related]
6. Role of mast cells and basophils in asthma. Redington AE; Polosa R; Walls AF; Howarth PH; Holgate ST Chem Immunol; 1995; 62():22-59. PubMed ID: 7546283 [No Abstract] [Full Text] [Related]
7. PDE IV as a target for anti-asthmatic therapy. O'Brien C Mol Med Today; 1997 Sep; 3(9):368-9. PubMed ID: 9302684 [No Abstract] [Full Text] [Related]
8. Phosphodiesterase inhibitors in airways disease. Fan Chung K Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289 [TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease. Doggrell SA Expert Opin Pharmacother; 2006 Mar; 7(4):485-8. PubMed ID: 16503820 [No Abstract] [Full Text] [Related]
10. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma. Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605 [TBL] [Abstract][Full Text] [Related]
12. Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation. Smith VB; Spina D Curr Opin Investig Drugs; 2005 Nov; 6(11):1136-41. PubMed ID: 16312135 [TBL] [Abstract][Full Text] [Related]
13. Regulation of leukotrienes in the management of asthma: biology and clinical therapy. Leff AR Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764 [TBL] [Abstract][Full Text] [Related]
14. Atopy, asthma, and the mycobacteria. Hopkin JM Thorax; 2000 Jun; 55(6):443-5. PubMed ID: 10817787 [No Abstract] [Full Text] [Related]
18. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lipworth BJ Lancet; 2005 Jan 8-14; 365(9454):167-75. PubMed ID: 15639300 [TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD). Barnette MS Prog Drug Res; 1999; 53():193-229. PubMed ID: 10616299 [TBL] [Abstract][Full Text] [Related]
20. Leukotrienes: new therapies and their influence on asthma. Coakley AL Br J Nurs; 2000 Jun 22-Jul 12; 9(12):750-4. PubMed ID: 11235295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]